Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This clinical study will assess the safety, tolerability and immunogenicity of VAL-506440 in healthy adult subjects.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion
Exclusion
Primary purpose
Allocation
Interventional model
Masking
201 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal